Cancer research has come a long way last 5 years.

Thanks to organizations like the Susan G. Komen for the Cure foundation once considered experimental drugs like tamoxifen are making headway toward a cure.

The findings showed that for every hundred women with breast cancer who completed a full five-year course of tamoxifen, the cancer came back in around six fewer women, compared to those who only took the drug for two years.
This latest British study, which was published in the Journal of Clinical Oncology on Monday, also found that an added benefit of taking tamoxifen for five years was that it reduced the risk of developing or dying from heart disease.